跳到正文
10月23日周五
  1. PubMed · European Journal of Pharmacology

    感染病学:Pharmacodynamic evaluation of the novel vancomycin derivative LYSC98.

    原文摘录:LYSC98 is a novel synthetic derivative from chemical modification of vancomycin. In this study, the antibacterial efficacy of LYSC98 was systematically evaluated against multiple clinically significant pathogens using Minimal Inhibitory Concentration (MIC … These results indicate that, within the strains, doses and models tested, LYSC98 is active against the Gram-positive species examined and is more effective than vancomycin in selected infection models

10月22日周四
  1. PubMed · Biochemical and Biophysical Research Communications

    新型抗PD-1/VEGF双特异性融合蛋白PKVBP的临床前设计与表征:增强VEGF结合能力用于肿瘤联合免疫治疗

    研究报告了新型抗PD-1/VEGF双特异性融合蛋白PKVBP的设计与表征:在Fc沉默的人IgG4骨架C端融合串联VEGFR1 D2结构域,实现四价VEGF结合。功能实验显示其可同时结合PD-1与VEGF,VEGF亲和力和结合能力显著强于贝伐珠单抗;体外稳定性和纯化研究显示良好理化稳定性。目前结果限于临床前分子表征,尚无临床疗效数据。

  2. PubMed · Oncogene

    Oncogene发表研究:肝细胞癌细胞FATP5缺失经肿瘤相关内皮细胞内长链脂肪酸蓄积与PPARγ–CXCL12轴塑造促肿瘤微环境

    研究发现肝细胞癌(HCC)细胞中脂肪酸转运蛋白5(FATP5)广泛下调,恶性细胞摄取长链脂肪酸(LCFAs)减少,过剩LCFAs被动蓄积于邻近的FATP3+肿瘤相关内皮细胞(TECs),激活PPARγ并旁分泌CXCL12,后者经CXCR4诱导浸润CD8+T细胞PD-1表达与终末耗竭,形成免疫抑制微环境并损害内皮屏障、增加血行转移风险。

10月21日周三
  1. PubMed · Sensors

    胸戴式光电容积脉搏波(PPG)信号质量优化方法研究:软硬件协同DC消除、线性预测编码伪差去除与softmax多通道融合

    一项方法学研究提出三种提升胸戴式光电容积脉搏波(PPG)信号质量的方法:软件定义控制覆盖商用传感器内置DC消除的软硬件协同设计、基于线性预测编码的伪差消除,以及softmax多通道数据融合。6名受试者坐位实验室数据评估显示,融合后复合波形信噪比为8.47±3.14 dB,略优于等增益(7.91±2.86 dB)与最大比合并(8.03±2.87 dB)(p=0.031),可去除DC偏移和阶跃伪差。

  2. PubMed · Cancer Letters

    食管鳞癌中超级增强子驱动circPRRC2B稳定TALDO1维持氧化还原稳态的机制研究

    研究者在食管鳞癌(ESCC)中鉴定出超级增强子(SE)经ETS1和HuR调控驱动的新型环状RNA circPRRC2B。体内外实验显示circPRRC2B而非PRRC2B促增殖、侵袭和转移,其机制为结合TALDO1并经BAP1去泛素化稳定TALDO1,激活磷酸戊糖通路、升高谷胱甘肽并抑制线粒体活性氧,维持氧化还原平衡;靶向circPRRC2B的反义寡核苷酸显著抑制ESCC生长。

10月20日周二
  1. EMA · Withdrawn Applications

    儿科学:Withdrawn application: Kaftrio, 01/09/2026

    原文摘录:Kaftrio - withdrawal of application for variation to marketing authorisation Application withdrawn The application for a change to this medicine's authorisation has been withdrawn ivacaftor / tezacaftor / elexacaftor Post-authorisation Human Overview Vert … News on Kaftrio Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026 18/09/2026 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2025 28/02/2025 Combination of cystic fibrosis medicines to treat patients with rare mutations 28/02/2025 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15/09/2023 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12/11/2021 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 March 2021 26/03/2021 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2020 26/06/2020 New medicine for cystic fibrosis patients 26/06/2020 More information on Kaftrio Kaftrio This page was last updated on 20/10/2026

    关注理由:如果关注儿科学,这条临床试验动态可用于了解研究设计,主要终点和试验阶段建议查看原文。

  2. FDA · MedWatch Safety Alerts

    儿科学:Early Alert: Cardinal Health Issues Correction for Presource Packs Containing BD Alaris Pump Infusion Sets

    原文摘录:CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program

    关注理由:这篇儿科学内容涉及具体研究方向,原文中的样本、结局和限制有助于理解其价值。

  3. FDA · MedWatch Safety Alerts

    呼吸病学:Update: Import Alert for Certain Olympus Medical Devices Manufactured in Japan - Letter to Health Care Providers

    原文摘录:October 20, 2026 The U.S. Food and Drug Administration (FDA) is alerting health care providers about an import alert for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries. … Additional Resources Import Alert 89-04 [10/19/2026] FDA Issues Two Warning Letters to Leading Manufacturer of Endoscopes [01/10/2023] Warning Letters Olympus Medical Systems Corporation Warning Letter [10/07/2026] Olympus Medical Systems Corporation Warning Letter (Hinode) [03/15/2023] Olympus Medical Systems Corporation Warning Letter (Hachioji-shi) [12/12/2022] Aizu Olympus Warning Letter [11/02/2022] Infections Associated with Reprocessed Duodenoscopes [06/30/2022] Infections Associated with Reprocessed Urological Endoscopes - Letter to Health Care Providers [04/01/2021]

    关注理由:这条呼吸病学内容涉及相关临床或研究问题,建议查看原文中的方法与适用范围。

  4. FDA · MedWatch Safety Alerts

    儿科学:Early Alert: Cardinal Health Updates Use Instructions for Presource Packs Containing BD Alaris Pump Infusion Sets

    原文摘录:CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program

    关注理由:这条儿科学资料涉及具体临床问题,研究人群、方法和结局指标可以结合原文进一步查看。

10月17日周六
10月16日周五
  1. EMA · News and Safety Reviews

    内分泌与代谢:Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026

    原文摘录:Image credit: © Marcos Osorio/Stocksy | stock.adobe.com Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026 16 October 2026 Six new medicines recommended for approval; another five medicines recommended for … eu All other enquiries please submit your request via the online form Follow us on Bluesky Related medicine information Foundayo Rasonque Yuviwel Fovlussea Neuzafy Kizfizo Kyinsu Talvey Tukysa Tryngolza Yartemlea Mylotarg Truqap Ibrance

    关注理由:这条内分泌与代谢资料涉及具体临床问题,研究人群、方法和结局指标可以结合原文进一步查看。

  2. PubMed · Biochimica et Biophysica Acta (BBA) - Biomembranes

    细胞内固体核磁共振研究噬菌体感染杀鲑气单胞菌引起的膜扰动

    一项体外/活菌固体核磁共振研究以氘代棕榈酸标记杀鲑气单胞菌亚种完整菌膜,比较A-layer阳性噬菌体敏感株AS-R3、A-layer阴性敏感株AS-R5与不敏感株BIM93在噬菌体SW69-9暴露后的膜序变化。敏感株膜序明显下降,AS-R5活力显著丧失,BIM93维持膜结构与活力,AS-R3呈膜扰动但裂解有限的中间表型,提示噬菌体诱导的膜扰动取决于噬菌体敏感性与细菌包膜结构。

  3. PubMed · American Journal of Physiology-Renal Physiology

    小鼠远端肾单位KCC3a在碱血症时的调控表现出性别二态性(动物研究)

    美国生理学会旗下American Journal of Physiology-Renal Physiology发表的C57BL/6J小鼠研究显示,NaHCO₃负荷10天使雄鼠肾脏KCC3a蛋白丰度上调,雌鼠则无变化,基线表达和mRNA水平相近。去睾可消除雄鼠上调,补5α-双氢睾酮仅部分恢复,卵巢切除不影响雌鼠反应,提示睾丸来源因子(非睾酮单独)参与雄性特异的代谢性碱中毒肾脏适应调控。

  4. WHO · Disease Outbreak News OData

    感染病学:Middle East respiratory syndrome coronavirus - Kingdom of Saudi Arabia

    原文摘录:Disease Outbreak News Middle East respiratory syndrome coronavirus - Kingdom of Saudi Arabia 15 October 2026 See all DONs related to this event Situation at a glance Between 1 January and 5 October 2026, the Kingdom of Saudi Arabia reported eight laborato … int/emergencies/disease-outbreak-news/item/2026-DON618 See all DONs related to this event

10月15日周四
  1. EMA · News and Safety Reviews

    肿瘤学:EMA recommends authorisation of Rasonque for metastatic pancreatic cancer

    原文摘录:Image credit: © Chinnapong | stock.adobe.com EMA recommends authorisation of Rasonque for metastatic pancreatic cancer 15 October 2026 Phased review fast tracks assessment of medicine addressing unmet medical need News Human Innovation Medicines EMA’s hum … eu All other enquiries Please submit your request via the online form Follow us on Bluesky Related medicine information Rasonque

    关注理由:这条肿瘤学内容涉及相关临床或研究问题,建议查看原文中的方法与适用范围。

  2. PubMed · Human Brain Mapping

    医学研究:Association Between Gray Matter Microstructure and Glucose Metabolism in Older Adults With Cognitive Decline: A Multimodal Imaging Study.

    原文摘录:Cortical glucose hypometabolism is a well-established early marker of neurodegeneration in dementia, mainly reflecting neuronal and synaptic dysfunction. Its relationship with underlying microstructural alterations remains unclear.

    关注理由:这条医学研究内容涉及队列研究,理解结果前可以先看研究人群、暴露定义和结局指标。

  3. PubMed · Virology

    呼吸病学:Influenza viruses as vaccine vectors: Historical background and future directions.

    原文摘录:Influenza viruses have served as experimental vaccine vectors for more than three decades, combining such advantages as mucosal delivery, segmented reverse genetics and clinically established attenuation strategies. … However, given that influenza B strains in trivalent LAIVs are particularly potent inducers of immune responses, further development of this vector platform could not only overcome the packaging constraints of the influenza genome for foreign inserts but also enable the creation of effective multivalent vaccines against the most epidemiologically relevant respiratory pathogens

10月14日周三
  1. PubMed · Atherosclerosis

    动物与体外研究显示PlGF通过抗炎巨噬细胞/TGF-β1轴调节血管平滑肌细胞表型增强动脉粥样硬化斑块稳定性

    动脉粥样硬化基础研究(ApoE-/-高脂饮食小鼠及人颈动脉VSMCs体外实验)显示,胎盘生长因子(PlGF)在稳定人类斑块纤维帽和肩部表达升高。PlGF给药7天后小鼠斑块纤维帽与肩部PlGF、α-SMA和TGF-β1增加,主动脉根部斑块面积缩小;机制上PlGF促使巨噬细胞向抗炎表型极化、增加TGF-β1分泌,上调VSMCs的α-SMA。

  2. PubMed · Biochimica et Biophysica Acta (BBA) - General Subjects

    机制研究:microRNA-145 经抑制TGFβR-II与自噬延缓颈动脉斑块进展(apoE−/−小鼠与血管平滑肌细胞实验)

    临床前机制研究发现,III-IV级狭窄颈动脉斑块中miR-145水平显著低于对照。在高胆固醇饮食apoE−/−小鼠模型中,antagomiR-145抑制miR-145后斑块体积增大、LC3-II表达升高,电镜证实自噬体增多;miR-145在血管平滑肌细胞中抑制TGFβR-II与自噬,siRNA沉默TGFβR-II可复现antagomiR-145效应。

  3. PubMed · International Journal of Epidemiology

    挪威母婴队列研究:孕期抗抑郁药暴露与子代14岁青春期发育时点的关联

    挪威母亲、父亲与儿童队列研究联合挪威医学出生登记分析1396例孕前有抑郁/焦虑母亲的单胎出生,按轨迹模型分为持续用药、孕早/晚期停药与未暴露组,以14岁青春期发育量表分类早熟、正常与延迟 puberty。与未暴露相比,持续用药及停药组早熟加权风险比(wRR)0.77–0.82,未见升高;延迟青春期共17例(1.2%),粗估计提示风险可能更高。研究为观察性设计,性别差异与延迟结局结论需谨慎解读。

10月13日周二
10月12日周一
  1. PubMed · Biomacromolecules

    血红蛋白-PEG 超分子聚合平衡研究为尺寸可控聚合物颗粒提供结构基础(Biomacromolecules 发表)

    研究者将血红蛋白(Hb)的β亚基经不同分子量(10、40 kDa)四臂PEG桥接构建双环单体,其可经浓度依赖的超分子开环聚合,从离散单体可控地形成聚合物颗粒直至凝胶网络,并用 DBBF 对 Hb 进行分子内 ββ 交联实现各聚合物物种的共价固定,固定产物保留了特征性 O2 结合性质。

  2. PubMed · American Journal of Physiology-Heart and Circulatory Physiology

    PASC患者直立与运动不耐受伴交感神经调控和心脏储备正常:一项微神经图与心脏MRI对照研究

    Erin J Howden团队在American Journal of Physiology-Heart and Circulatory Physiology发表研究,纳入35例症状超过3个月、无明显合并症的PASC成人及12名年龄性别匹配的康复对照,进行CPET、超声心动图、静息与运动心脏MRI及腓总神经微神经图MSNA记录和60°直立倾斜试验。

  3. PubMed · Archives of Biochemistry and Biophysics

    肿瘤学:The p.V27A variant of l-asparaginase II minimizes glutaminase activity without compromising anti-leukemic function.

    原文摘录:l-Asparaginase is a fundamental chemotherapeutic agent for acute lymphoblastic leukemia (ALL) that depletes circulating asparagine to induce apoptosis in leukemic blasts. … V27A variant delivers an improved safety profile without compromising therapeutic potency, emerging as